HLS Therapeutics Inc. (TSX:HLS)
Canada · Delayed Price · Currency is CAD 4.430
+0.030 (0.68%)
Apr 10, 2026, 3:59 PM EST
HLS Therapeutics Revenue
In the year 2025, HLS Therapeutics had annual revenue of $55.50M USD, down -1.98%. HLS Therapeutics had revenue of $15.20M in the quarter ending December 31, 2025, a decrease of -2.23%.
Revenue
$55.50M
Revenue Growth
-1.98%
P/S Ratio
1.87
Revenue / Employee
$652.94K
Employees
85
Market Cap
142.30M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 55.50M | -1.12M | -1.98% |
| Dec 31, 2024 | 56.62M | -6.46M | -10.23% |
| Dec 31, 2023 | 63.07M | 1.61M | 2.61% |
| Dec 31, 2022 | 61.47M | 1.46M | 2.43% |
| Dec 31, 2021 | 60.01M | 3.90M | 6.95% |
| Dec 31, 2020 | 56.11M | 1.95M | 3.60% |
| Dec 31, 2019 | 54.16M | -7.26M | -11.81% |
| Dec 31, 2018 | 61.42M | -13.67M | -18.20% |
| Dec 31, 2017 | 75.08M | 21.05M | 38.96% |
| Dec 31, 2016 | 54.03M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ascend Wellness Holdings | 686.36M |
| Organigram Global | 279.99M |
| Auxly Cannabis Group | 151.48M |
| Planet 13 Holdings | 141.74M |
| Medexus Pharmaceuticals | 136.34M |
| Cannara Biotech | 112.25M |
| Decibel Cannabis Company | 109.31M |
| Charlotte's Web Holdings | 68.41M |